Non-virally modified human mesenchymal stem cells produce ciliary neurotrophic factor in biodegradable fibrin-based 3D scaffolds

Journal of Pharmaceutical Sciences

Volumn 101, Issue 4, 2012, Pages 1546-1554

  Shakhbazau, Antos ^a,b   Shcharbin, Dzmitry ^c   Petyovka, Natalya ^d   Goncharova, Natalya ^d   Seviaryn, Ihar ^d   Kosmacheva, Svetlana ^d   Bryszewska, Maria ^e   Potapnev, Mihail ^d  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c INSTITUTE OF PHOTOBIOLOGY   (Belarus)

^d Republic Centre for Hematology and Transfusiology   (Belarus)

^e UNIVERSITY OF LODZ   (Poland)

Author keywords

CNTF; Fibrin scaffold; Gene therapy; Human mesenchymal stem cells; Non viral gene delivery; PAMAM dendrimers; Polymeric biomaterials; Transfection

Indexed keywords

ACRYLIC ACID METHYL ESTER; CILIARY NEUROTROPHIC FACTOR; DENDRIMER; ETHYLENEDIAMINE; FIBRIN; GREEN FLUORESCENT PROTEIN; MOLECULAR SCAFFOLD; NEUROTROPHIN; POLYAMIDOAMINE;

ADULT STEM CELL; ARTICLE; BIOARTIFICIAL ORGAN; BIODEGRADABILITY; CONTROLLED STUDY; CYTOTOXICITY; GENE CASSETTE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTERNAL RIBOSOME ENTRY SITE; MESENCHYMAL STEM CELL; NONVIRAL GENE DELIVERY SYSTEM; PROTEIN EXPRESSION; TRANSGENE;

EID: 84857503893     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23033     Document Type: Article

References (51)

1. Mazzini L, Vercelli A, Mareschi K, Ferrero I, Testa L, Fagioli F. 2009. Mesenchymal stem cells for ALS patients. Amyotroph Lateral Scler 10:123-124.
2. Vercelli A, Mereuta OM, Garbossa D, Muraca G, Mareschi K, Rustichelli D, Ferrero I, Mazzini L, Madon E, Fagioli F. 2008. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 31:395-405.
3. Shakhbazau A, Isayenka I, Kartel N, Goncharova N, Seviaryn I, Kosmacheva S, Potapnev M, Shcharbin D, Bryszewska M. 2010. Transfection efficiencies of PAMAM dendrimers correlate inversely with their hydrophobicity. Int J Pharm 383:228-235.
4. Ronsyn MW, Daans J, Spaepen G, Chatterjee S, Vermeulen K, D'Haese P, Van Tendeloo VF, Van Marck E, Ysebaert D, Berneman ZN, Jorens PG, Ponsaerts P. 2007. Plasmid-based genetic modification of human bone marrow-derived stromal cells: Analysis of cell survival and transgene expression after transplantation in rat spinal cord. BMC Biotechnol 7:90-107.
5. Gupta U, Agashe HB, Asthana A, Jain NK. 2006. A review of in vitro - in vivo investigations on dendrimers: The novel nanoscopic drug carriers. Nanomedicine 2:66-73.
6. Svenson S, Tomalia DA. 2005. Dendrimers in biomedical applications-Reflections on the field. Adv Drug Deliv Rev 57:2106-2129.
7. Tomalia DA. 1991. Dendrimer research. Science 252:1231.
8. Barsotti MC, Magera A, Armani C, Chiellini F, Felice F, Dinucci D, Piras AM, Minnocci A, Solaro R, Soldani G, Balbarini A, Di SR. 2011. Fibrin acts as biomimetic niche inducing both differentiation and stem cell marker expression of early human endothelial progenitor cells. Cell Prolif 44:33-48.
9. Burdick JA, Vunjak-Novakovic G. 2009. Engineered microenvironments for controlled stem cell differentiation. Tissue Eng Part A 15:205-219.
10. Engler AJ, Sen S, Sweeney HL, Discher DE. 2006. Matrix elasticity directs stem cell lineage specification. Cell 126:677-689.
11. Ifkovits JL, Devlin JJ, Eng G, Martens TP, Vunjak-Novakovic G, Burdick JA. 2009. Biodegradable fibrous scaffolds with tunable properties formed from photo-cross-linkable poly(glycerol sebacate). ACS Appl Mater Interfaces 1:1878-1886.
12. Shcharbin D, Pedziwiatr E, Bryszewska M. 2009. How to study dendriplexes I: Characterization. J Control Release 135:186-197.
13. Shakhbazau AV, Petyovka NV, Kosmacheva SM, Potapnev MP. 2011. Neurogenic induction of human mesenchymal stem cells in fibrin 3D matrix. Bull Exp Biol Med 150:547-550.
14. Kohyama J, Abe H, Shimazaki T, Koizumi A, Nakashima K, Gojo S, Taga T, Okano H, Hata J, Umezawa A. 2001. Brain from bone: Efficient "meta-differentiation" of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent. Differentiation 68:235-244.
15. Shakhbazau A, Shcharbin D, Seviaryn I, Goncharova N, Kosmacheva S, Potapnev M, Gabara B, Ionov M, Bryszewska M. 2010. Use of polyamidoamine dendrimers to engineer BDNF-producing human mesenchymal stem cells. Mol Biol Rep 37:2003-2008.
16. Gorodetsky R, Levdansky L, Gaberman E, Gurevitch O, Lubzens E, McBride WH. 2011. Fibrin microbeads loaded with mesenchymal cells support their long-term survival while sealed at room temperature. Tissue Eng Part C Methods 17:745-755.
17. Peterbauer-Scherb A, Danzer M, Gabriel C, van GM, Redl H, Wolbank S. 2011. In vitro adipogenesis of adipose-derived stem cells in 3D fibrin matrix of low component concentration. J Tissue Eng Regen Med.DOI: 10.1002/term.446.
18. Coppola V, Kucera J, Palko ME, Martinez-De Velasco J, Lyons WE, Fritzsch B, Tessarollo L. 2001. Dissection of NT3 functions in vivo by gene replacement strategy. Development 128:4315-4327.
19. Reichardt LF. 2006. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 361:1545-1564.
20. Hu Y, Leaver SG, Plant GW, Hendriks WT, Niclou SP, Verhaagen J, Harvey AR, Cui Q. 2005. Lentiviral-mediated transfer of CNTF to schwann cells within reconstructed peripheral nerve grafts enhances adult retinal ganglion cell survival and axonal regeneration. Mol Ther 11:906-915.
21. Tuszynski MH, Murai K, Blesch A, Grill R, Miller I. 1997. Functional characterization of NGF-secreting cell grafts to the acutely injured spinal cord. Cell Transplant 6:361-368.
22. Mason MR, Tannemaat MR, Malessy MJ, Verhaagen J. 2011. Gene therapy for the peripheral nervous system: A strategy to repair the injured nerve? Curr Gene Ther 11:75-89.
23. Li Q, Ping P, Jiang H, Liu K. 2006. Nerve conduit filled with GDNF gene-modified Schwann cells enhances regeneration of the peripheral nerve. Microsurgery 26:116-121.
24. Weidner N, Blesch A, Grill RJ, Tuszynski MH. 1999. Nerve growth factor-hypersecreting Schwann cell grafts augment and guide spinal cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of L1. J Comp Neurol 413:495-506.
25. Eggers R, Hendriks WT, Tannemaat MR, van Heerikhuize JJ, Pool CW, Carlstedt TP, Zaldumbide A, Hoeben RC, Boer GJ, Verhaagen J. 2008. Neuroregenerative effects of lentiviral vector-mediated GDNF expression in reimplanted ventral roots. Mol Cell Neurosci 39:105-117.
26. Tannemaat MR, Eggers R, Hendriks WT, de Ruiter GC, van Heerikhuize JJ, Pool CW, Malessy MJ, Boer GJ, Verhaagen J. 2008. Differential effects of lentiviral vector-mediated overexpression of nerve growth factor and glial cell line-derived neurotrophic factor on regenerating sensory and motor axons in the transected peripheral nerve. Eur J Neurosci 28:1467-1479.
27. Slavik J. 1982. Anilinonaphthalene sulfonate as a probe of membrane composition and function. Biochim Biophys Acta 694:1-25.
28. Oliveira JM, Sousa RA, Malafaya PB, Silva SS, Kotobuki N, Hirose M, Ohgushi H, Mano JF, Reis RL. 2011. In vivo study of dendronlike nanoparticles for stem cells "tune-up": From nano to tissues. Nanomedicine 7:914-924.
29. Santos JL, Oramas E, Pego AP, Granja PL, Tomas H. 2009. Osteogenic differentiation of mesenchymal stem cells using PAMAM dendrimers as gene delivery vectors. J Control Release 134:141-148.
30. Ferraro GB, Alabed YZ, Fournier AE. 2004. Molecular targets to promote central nervous system regeneration. Curr Neurovasc Res 1:61-75.
31. Sendtner M, Carroll P, Holtmann B, Hughes RA, Thoenen H. 1994. Ciliary neurotrophic factor. J Neurobiol 25:1436-1453.
32. Oppenheim RW, Prevette D, Yin QW, Collins F, MacDonald J. 1991. Control of embryonic motoneuron survival in vivo by ciliary neurotrophic factor. Science 251:1616-1618.
33. Forger NG, Roberts SL, Wong V, Breedlove SM. 1993. Ciliary neurotrophic factor maintains motoneurons and their target muscles in developing rats. J Neurosci 13:4720-4726.
34. Sendtner M, Kreutzberg GW, Thoenen H. 1990. Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 345:440-441.
35. Sahenk Z, Seharaseyon J, Mendell JR. 1994. CNTF potentiates peripheral nerve regeneration. Brain Res 655:246-250.
36. Stankoff B, Aigrot MS, Noel F, Wattilliaux A, Zalc B, Lubetzki C. 2002. Ciliary neurotrophic factor (CNTF) enhances myelin formation: A novel role for CNTF and CNTF-related molecules. J Neurosci 22:9221-9227.
37. Helgren ME, Squinto SP, Davis HL, Parry DJ, Boulton TG, Heck CS, Zhu Y, Yancopoulos GD, Lindsay RM, DiStefano PS. 1994. Trophic effect of ciliary neurotrophic factor on denervated skeletal muscle. Cell 76:493-504.
38. Martin D, Merkel E, Tucker KK, McManaman JL, Albert D, Relton J, Russell DA. 1996. Cachectic effect of ciliary neurotrophic factor on innervated skeletal muscle. Am J Physiol 271:R1422-R1428.
39. Vergara C, Ramirez B. 2004. CNTF, a pleiotropic cytokine: Emphasis on its myotrophic role. Brain Res Brain Res Rev 47:161-173.
40. Ye JH, Houle JD. 1997. Treatment of the chronically injured spinal cord with neurotrophic factors can promote axonal regeneration from supraspinal neurons. Exp Neurol 143:70-81.
41. Xu JJ, Chen EY, Lu CL, He C. 2009. Recombinant ciliary neurotrophic factor promotes nerve regeneration and induces gene expression in silicon tube-bridged transected sciatic nerves in adult rats. J Clin Neurosci 16:812-817.
42. Lu Z, Hu X, Zhu C, Wang D, Zheng X, Liu Q. 2009. Overexpression of CNTF in mesenchymal stem cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice. J Neuroimmunol 206:58-69.
43. Emerich DF, Thanos CG, Sanberg PR. 2008. Intraventricular implant of encapsulated CNTF-secreting fibroblasts ameliorates motor deficits in aged rats. Curr Aging Sci 1:105-111.
44. Cao Q, He Q, Wang Y, Cheng X, Howard RM, Zhang Y, DeVries WH, Shields CB, Magnuson DS, Xu XM, Kim DH, Whittemore SR. 2010. Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury. J Neurosci 30:2989-3001.
45. Weinelt S, Peters S, Bauer P, Mix E, Haas SJ, Dittmann A, Petrov S, Wree A, Cattaneo E, Knoblich R, Strauss U, Rolfs A. 2003. Ciliary neurotrophic factor overexpression in neural progenitor cells (ST14A) increases proliferation, metabolic activity, and resistance to stress during differentiation. J Neurosci Res 71:228-236.
46. Sieving PA, Caruso RC, Tao W, Coleman HR, Thompson DJ, Fullmer KR, Bush RA. 2006. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: Phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci U S A 103:3896-3901.
47. Kemp SW, Webb AA, Dhaliwal S, Syed S, Walsh SK, Midha R. 2011. Dose and duration of nerve growth factor (NGF) administration determine the extent of behavioral recovery following peripheral nerve injury in the rat. Exp Neurol 229:460-470.
48. Heymach JV Jr., Kruttgen A, Suter U, Shooter EM. 1996. The regulated secretion and vectorial targeting of neurotrophins in neuroendocrine and epithelial cells. J Biol Chem 271:25430-25437.
49. Zhang G, Drinnan CT, Geuss LR, Suggs LJ. 2010. Vascular differentiation of bone marrow stem cells is directed by a tunable three-dimensional matrix. Acta Biomater 6:3395-3403.
50. Engler AJ, Sweeney HL, Discher DE, Schwarzbauer JE. 2007. Extracellular matrix elasticity directs stem cell differentiation. J Musculoskelet Neuronal Interact 7:335.
51. Jin G, Prabhakaran MP, Ramakrishna S. 2011. Stem cell differentiation to epidermal lineages on electrospun nanofibrous substrates for skin tissue engineering. Acta Biomater 7:3113-3122.